Ambu A/S (AMBUb)

Currency in DKK
66.8
+0.1(+0.15%)
Closed·
AMBUb is included in our AI-picked strategies. See how they work
Fair Value
Day's Range
66.868.7
52 wk Range
60.5111.8
Key Statistics
Prev. Close
66.7
Open
66.9
Day's Range
66.8-68.7
52 wk Range
60.5-111.8
Volume
653.22K
Average Volume (3m)
973.98K
1-Year Change
-34.5739%
Book Value / Share
23.01
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
AMBUb Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
88.8
Upside
+32.93%
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a high earnings multiple

Ambu A/S News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Strong Sell
Moving Averages
Neutral

Analyst Ratings

4 Buy
4 Hold
0 Sell
Ratings:
8 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 88.8
(+32.93% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
UBS
Buy96.00+43.71%138.00Maintain12/05/2026
JPMorgan
Hold78.00+16.77%90.00Maintain05/02/2026
UBS
Buy138.00+106.59%139.00Maintain15/01/2026
Bernstein SocGen Group
Buy119.50+78.89%125.10Maintain17/12/2025
UBS
Buy139.00+108.08%147.00Maintain14/11/2025

Earnings

Latest Release
06/05/2026
EPS / Forecast
0.46 / 0.54
Revenue / Forecast
1.57B / 1.62B
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 1.79%
Dividend Yield
0.60%
Industry Median 4.65%
Annualised payout
0.41
Paid annually
5-Years Growth
+7.17%
Growth Streak

Ambu (AMBUb) Income Statement & Profits

Compare AMBUb to Peers and Sector

Metrics to compare
AMBUb
Peers
Sector
Relationship
P/E Ratio
37.1x21.5x−0.5x
PEG Ratio
1.250.130.00
Price/Book
2.9x3.1x2.6x
Price / LTM Sales
2.9x2.8x3.1x
Upside (Analyst Target)
30.2%38.3%53.2%
Fair Value Upside
Unlock23.9%6.2%Unlock

Ambu A/S, together with its subsidiaries, researches, develops, manufactures, markets, and sells medical technology solutions in North America, Europe, and internationally. The company offers endoscopy products, including bronchoscopes, video laryngoscopes, rhinolaryngoscopes, duodenoscopes, gastroscopes, cystoscopes, ureteroscopes, and displaying and processing units; neurology products, such as EEG and EMG electrodes, EMG guided injections, and intraoperative monitoring products; and cardiology products comprising ECG electrodes. It also provides airway management and anaesthesia products, which include double and single lumen tubes, endobronchial blockers, laryngeal and face masks, breathing bags, and resuscitators. In addition, the company offers emergency care and training products, such as extrication collars and ALS and BLS training manikins, as well as mobile workstations, IOMs, and patient monitoring and diagnostics devices. Ambu A/S was founded in 1937 and is headquartered in Ballerup, Denmark.

Employees
5200
Market
Denmark

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
74.52M28.41%4.97B
Other Institutional Investors
-3.87M-1.47%-257.95M
Public Companies & Retail Investors
191.69M73.07%12.79B
Total
262.34M100.00%17.5B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Vanguard World Fund - Vanguard International Growth Fund5.82%15,259,4651,017,806
ATP2.88%7,550,000503,585

People Also Watch

162.91
CINF
-2.47%
62.46
EUFI
+0.81%
24.20
LKFT
+1.51%
152.8
TRYG
-0.84%
42.62
HLUNb
+1.24%

FAQ

What Is the Ambu (Copenhagen: AMBUb) Share Price Today?

The Ambu stock price today is 66.8 DKK.

What Stock Exchange Does Ambu (AMBUb) Trade On?

Ambu is listed and trades on the Copenhagen Stock Exchange.

What Is the Ticker (Stock Symbol) for Ambu?

The stock symbol (also called a 'ticker') for Ambu is "AMBUb."

Does Ambu Pay Dividends? What’s The Current AMBUb Dividend Yield?

Yes, AMBUb Pays Dividends to its Shareholders. The current Ambu dividend yield is 0.61%.

What Is the Current Ambu Market Capitalisation?

As of today, Ambu (Copenhagen: AMBUb) market cap is 17.69B DKK.

What Is Ambu's (AMBUb) Earnings Per Share (TTM)?

The Ambu EPS is currently 1.8 (Trailing Twelve Months).

When Is the Next Ambu Earnings Date?

Ambu's next earnings report will be released on 26/08/2026.

Is AMBUb a Buy or Sell From a Technical Analyst Perspective?

Based on today's Ambu moving averages and other technical indicators, the daily buy/sell signal for AMBUb stock is Buy.

How Many Times Has Ambu Stock Split?

Ambu has split 4 times. (See the AMBUb stock split history page for full effective split date and price information.)

How Many Employees Does Ambu Have?

Ambu has 5200 employees, based on their latest Companies House report.

What is the current trading status of Ambu (Copenhagen: AMBUb)?

As of 27/05/2026, Ambu (AMBUb) is trading at a share price of 66.8 DKK, with a previous close of 66.7 DKK. The stock has fluctuated within a day range of 66.8 DKK to 68.7 DKK, while its 52-week range spans from 60.5 DKK to 111.8 DKK.

What Is Ambu (AMBUb) Price Target According to Analysts?

The average 12-month price target for Ambu is 88.8 DKK, with a high estimate of 116.4 DKK and a low estimate of 65 DKK. 4 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +32.93% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.